All the XML tags (elements) and their definitions (where applicable) are described in this table. Some of the terms use controlled vocabulary as outlined on NGC Classification Scheme.
GEM definitions are displayed in an XML file at gem_defs.xml.
Concept |
Definition |
XML Element Tag |
Controlled Vocabulary |
|
|
<guideline.document> |
|
Identity |
|
<identity> |
|
Title |
Complete title of the guideline |
<guideline.title> |
|
Citation |
bibliographic citation |
<citation> |
|
Guideline Length |
number of pages in printed document |
<guideline.length> |
|
Release date |
date the guideline was released to public |
<release.date> |
|
Availability |
|
<availability> |
|
Electronic |
information regarding sources of guideline in electronic format |
<electronic> |
|
|
information regarding sources of guideline in print format |
<print> |
|
Contact |
person or organization to contact for additional information |
<contact> |
|
Status |
identifies whether the guideline is a revised or updated version of a previously issued document |
<status> |
|
Companion document |
refers to other documents (including Technical Reports, Consumer Guidelines, Quick Reference Guidelines produced by the guideline developer relevant to the guideline |
<companion.document> |
|
Patient Resources |
patient resources that are directly related, I.e., derived and/or prepared from the guideline |
<patient.resource> |
|
Adaptation |
identifies that the guideline has been adapted from another guideline |
<adaptation> |
|
Developer |
|
<developer> |
|
Developer Name |
organization(s) responsible for developing the guideline |
<developer.name> |
|
Developer Type |
organization type attribute-major designation or function (NGC) |
<developer.type> |
|
Committee Name |
formal name of committee withing developer organization responsible for developing guideline |
<committee.name> |
|
Committee expertise |
group composition - composition of the group that authored guideline |
<committee.expertise> |
|
Committee Member |
Name of committee member |
<committee.member> |
|
Member Expertise |
Background or expertise of an individual guideline committee member |
<member.expertise> |
|
Funding |
source(s) of financial support for guideline development, including grant numbers |
<funding> |
|
Endorser |
organization that has endorsed the guideline |
<endorser> |
|
Comparable Guideline |
another guideline on same topic, generally indicated by developing organization |
<comparable.guideline> |
|
Purpose |
|
<purpose> |
|
Main health practices, services or technologies considered |
Primary disease/Condition, health practice, service, or technology addressed in the guideline |
<main.focus> |
|
Category |
Classification of major focus of the guideline (NGC) |
<category> |
|
Rationale |
reasons for developing recommendations |
<rationale> |
|
Objective |
objectives - describes the objectives of the guideline |
<objective> |
|
Available options |
main management options considered; principal alternative preventive, diagnostic, or therapeutic strategies available |
<available.option> |
|
Implementation strategy |
specific strategies, aims, performance measures, or plans for implementing the recommendations |
<implementation.strategy> |
|
Health Outcomes |
describes the most important specific outcomes or performance measures considered in the guideline; includes pt outcomes and diagnostic test performance characteristics |
<health.outcome> |
|
Exceptions |
situations in which socially relevant factors permit an exception to be made in applying the guidelines; include home and family situation, constraints on health care delivery system (IOM) |
<exception> |
|
Intended audience |
|
<intended.audience> |
|
Care setting |
describes the settings in which guideline is intended for use |
<care.setting> |
|
Users |
classifies the groups intended to use the guideline |
<user> |
|
Clinical Specialty |
classifies the clinical specialties that might use the guideline professionally (NGC) |
<clinical.specialty> |
|
Target population |
|
<target.population> |
|
Eligibility |
describes
target population; identifies restrictions on guideline use such as
within an MCO or geographic region. |
<eligibility> |
|
Inclusion criterion |
A criterion whose presence is necessary for the guideline recommendations to be applicable |
<inclusion_criterion> |
|
Exclusion Criterion |
A criterion whose presence excludes the applicability of the recommendations |
<exclusion.criterion> |
|
Age |
For the purposes of searching, NGC classifies the target population by age and sex |
<age> |
|
Sex |
|
<sex> |
|
Method of development |
|
<development.method> |
|
Description of evidence collection |
methods used to collect (identify and retrieve) scientific evidence on which recommendations are based (IOM) |
<description.evidence.collection> |
|
Method of collecting evidence |
classifies methods used to collect evidence (NGC) |
<method.evidence.collection> |
|
Number of source documents |
Number of source documents identified by methods described above |
<number.source.documents> |
|
Evidence time period |
publication dates of the most recent evidence considered |
<evidence.time.period> |
|
Method evidence grading |
criteria used to gauge the quality of information collected from different sources |
<method.evidence.grading> |
NGC Methods Used to Assess the Quality and Strength of the Evidence |
Rating Scheme |
Presents rating scheme for strength of evidence |
<rating.scheme> |
|
Description of Method for combining evidence/opinion |
formal method of synthesis used to combine the scientific evidence quantitatively or otherwise; formal expert or group judgment techniques used to reach professional consensus |
<description.evidence.combination> |
|
Method combining evidence/opinion |
Classifies methods used by developer to evaluate data in the evidence (NGC) |
<method.evidence.combination> |
|
Cost Analysis |
Describes any formal cost analysis performed |
<cost.analysis> |
|
Specification of benefit/harm |
Description of general benefits and risks associated with implementation of guideline |
<specification.harm.benefit> |
|
Quantification of benefit/harm |
Quantification of general benefits or risks associated with implementation of guideline |
<quantification.harm.benefit> |
|
Role of value judgment |
implicit or explicit process for judging relative desirability of health, economic, and process outcomes associated with alternative practices |
<role.value.judgment> |
|
Role of patient preference |
the role of patient preferences for different possible outcomes of care when the appropriateness of a clinical intervention involves a substantial element of personal choice or values (IOM) |
<role.patient.preference> |
|
Qualifying statement |
Important caveat relating to major recommendation. Identifies area of uncertainty |
<qualifying.statement> |
|
Knowledge Components |
|
<knowledge.components> |
|
Recommendation |
A statement of appropriate practice specified in the guideline |
<recommendation> |
|
Conditional |
If then statement |
<conditional> |
|
Decision variable |
A condition that must be tested to indicate the appropriateness of an action |
<decision.variable> |
|
Value |
A specified state of a decision variable |
<value> |
|
Decision Variable Description |
Text that provides and amplifies information about a decision variable |
<decision.variable.description> |
|
Test parameter |
Information about the quality of a decision variable |
<test.parameter> |
|
Sensitivity |
An indication of the probability of the decision variable being present under specific clinical circumstances |
<sensitivity> |
|
Specificity |
An indication of the probability of the decision variable being absent under specific clinical circumstances |
<specificity> |
|
Predictive value |
An indication of the probability of an outcome occurring when a particular value of the decision variable is present |
<predictive.value> |
|
Decision variable cost |
The cost of testing a decision variable |
<decision.variable.cost> |
|
Action |
Appropriate activities given specific clinical circumstances defined by values of decision variables |
<action> |
|
Action Benefit |
An improvement in status of some measured outcome that may occur as a result of following a recommendation |
<action.benefit> |
|
Risk/harm |
Risk or adverse outcome associated with implementation of a recommendation |
<action.risk.harm> |
|
Action description |
Text that provides and amplifies information about an action |
<action.description> |
|
Action cost |
Cost of performing a specific action |
<action.cost> |
|
Reason |
An explanation or justification for a recommendation |
<reason> |
|
Evidence quality |
An indication of methodologic rigor of the studies that support a recommendation |
<evidence.quality> |
|
Strength of recommendation |
An indication of the guideline developers' level of support for a given recommendation |
<recommendation.strength> |
|
Flexibility |
Indications of optional actions |
<flexibility> |
|
Logic |
Boolean operators that indicate how decision variables and actions are to be combined |
<logic> |
|
Cost |
Overall cost of performing a specific conditional recommendation |
<cost> |
|
Link |
Indicator of a relationship between this conditional and other knowledge component(s) |
<link> |
|
Reference |
Specific citation relevant to this conditional recommendation |
<reference> |
|
Certainty |
Indication of the likelihood that this recommendation will lead to specified outcomes |
<certainty> |
|
Imperative |
Recommendation directed at the entire eligible population without limitation |
<imperative> |
|
Directive |
An appropriate activity for the eligible population |
<directive> |
|
Directive Benefit |
An improvement in status that may occur as a result of following a directive |
<directive.benefit> |
|
Risk/harm |
Risk or adverse outcome associated with implementation of a directive |
<directive.risk.harm> |
|
Description |
Text that provides and amplifies information about a directive |
<directive.description> |
|
Directive_Cost |
Cost of performing a specific directive |
<directive.cost> |
|
Reason |
An explanation or justification for a recommendation |
<reason> |
|
Evidence quality |
An indication of methodologic rigor of the studies that support a recommendation |
<evidence.quality> |
|
Strength of recommendation |
An indication of the guideline developers' level of support for a given recommendation |
<recommendation.strength> |
|
Flexibility |
Indication of options in performing imperative |
<flexibility> |
|
Logic |
Boolean operators that indicate how directives are to be combined |
<logic> |
|
Cost |
Overall cost of performing a n imperative recommendation |
<cost> |
|
Link |
Indicator of a relationship between this imperative and other knowledge component(s) |
<link> |
|
Reference |
Specific citation relevant to this imperative recommendation |
<reference> |
|
Certainty |
Indication of the likelihood that this recommendation will lead to specified outcomes |
<certainty> |
|
Definition |
|
<definition> |
|
Term |
A word or phrase defined in the guideline |
<term> |
|
Term meaning |
The precise definition of the term for guideline purposes |
<term.meaning> |
|
Algorithm |
A sequential representation (often graphic) of stages in health management described by a guideline |
<algorithm> |
|
Action Step |
Specifies clinical actions that are to be performed in the patient-care process (GLIF) |
<action.step> |
|
Conditional Step |
Directs flow from one guideline step to another based on the evaluation of a criterion (GLIF) |
<conditional.step> |
|
Branch Step |
Directs flow in alternate directions (GLIF) |
<branch.step> |
|
Synchronization Step |
Represents a convergence of other steps (GLIF) |
<synchronization.step> |
|
Testing |
|
<testing> |
|
External review |
evaluator and/or methods used to review or validate the recommendations of the guideline |
<external.review> |
|
Review Method |
Summarizes methods used to review or validate the guideline (NGC) |
<review.method> |
|
Pilot testing |
Validation status testing , pilot, production |
<pilot.testing> |
|
Revision Plan |
|
<revision.plan> |
|
Expiration |
Time (or date) that recommendations cease to be valid |
<expiration> |
|
Scheduled review |
Future time (or date) planned to review continued appropriateness of recommendations |
<scheduled.review> |
Last modified: 6/15/2005 |